Novartis shelves potential blockbuster pelacarsen as landmark study fails

🇨🇭 Investing.com (CH) —
Novartis shelves potential blockbuster pelacarsen as landmark study fails

AI Summary

Novartis has shelved development of pelacarsen after a landmark study failed to meet its goals. The decision halts a drug that had been considered a potential blockbuster.

Markets Health Novartis pelacarsen clinical study drug development trial failure

Read original source →